Cargando…
The proof for new oral anticoagulants: clinical trial evidence
INTRODUCTION: Patients undergoing elective total hip or total knee replacement surgery are at increased risk of venous thromboembolism in the post-operative period and are recommended to receive thromboprophylaxis for 10–35 days. Although several thromboprophylactic agents are available, these are a...
Autor principal: | Huisman, Menno V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3150805/ https://www.ncbi.nlm.nih.gov/pubmed/21892362 http://dx.doi.org/10.1007/s12570-011-0063-9 |
Ejemplares similares
-
When to withhold oral anticoagulation in atrial fibrillation – an overview of frequent clinical discussion topics
por: Seelig, Jaap, et al.
Publicado: (2019) -
The Role of Anticoagulation Clinics in the Era of New Oral Anticoagulants
por: Testa, Sophie, et al.
Publicado: (2012) -
New horizons in anticoagulation: Direct oral
anticoagulants and their implications in oral surgery
por: Serrano-Sánchez, Víctor, et al.
Publicado: (2017) -
Coagulation assessment with the new generation of oral anticoagulants
por: Pollack, Charles V
Publicado: (2016) -
Direct Oral Anticoagulants in Cirrhotic Patients: Current Evidence and Clinical Observations
por: Elhosseiny, Sherif, et al.
Publicado: (2019)